This figure provides an overview of the options for treatment of patients with generalized myasthenia gravis who are acetylcholine receptor positive.

Figure 1Anticipated Place in Therapy of Efgartigimod Alfa for Anti-AChR Antibody-Positive gMG

AChEI = acetylcholinesterase inhibitor; AChR = acetylcholine receptor; CS = corticosteroids; gMG = generalized myasthenia gravis; NSIST = nonsteroidal immunosuppressant.

From: Efgartigimod Alfa (Vyvgart)

Cover of Efgartigimod Alfa (Vyvgart)
Efgartigimod Alfa (Vyvgart): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive [Internet].
Copyright Notice

Copyright © 2024 - Canadian Agency for Drugs and Technologies in Health. Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND).

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.